BRCA1 and cancer: Regarding cell-extrinsic mechanisms, DNA damage mediated by PARP inhibition in BRCA1-deficient cancers induces T-cell infiltration and activation via the cyclic GMP-AMP synthase (cGAS)/stimulator of interferon genes (STING) innate immunity pathway, leading to increased expression of type I interferons12,13.